Location History:
- Zionsville, IN (US) (2012)
- Brownsburg, IN (US) (2019)
Company Filing History:
Years Active: 2012-2019
Title: The Innovative Contributions of Stacy Jo Keding
Introduction
Stacy Jo Keding is a notable inventor based in Brownsburg, Indiana. She has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that target specific receptors in the body. With a total of two patents to her name, Keding's work is paving the way for advancements in medical treatments.
Latest Patents
Keding's latest patents include innovative compounds that serve as Ghrelin O-acyl transferase (GOAT) inhibitors. These novel inhibitors and their salts are designed to provide pharmaceutical compositions that can have a substantial impact on various health conditions. Additionally, she has developed 1, 5-diphenyl-3-benzylamino-1, 5-dihydropyrrolidin-2-one, which acts as a CB1 receptor modulator. This compound is particularly useful for reducing body weight in mammals, treating cognitive impairment associated with schizophrenia, and mitigating treatment-emergent weight gain observed during antipsychotic treatment.
Career Highlights
Keding is currently employed at Eli Lilly and Company, a leading pharmaceutical firm known for its commitment to innovation and research. Her role at the company allows her to contribute to groundbreaking research and development in the pharmaceutical industry.
Collaborations
Throughout her career, Keding has collaborated with esteemed colleagues, including Christopher Stanley Galka and Erik James Hembre, II. These collaborations have further enhanced her research and the impact of her inventions.
Conclusion
Stacy Jo Keding's contributions to the field of pharmaceuticals through her innovative patents demonstrate her commitment to advancing medical science. Her work continues to influence the development of effective treatments for various health conditions.